Previous
Previous

ImmTune has been awarded the prestigious Biomedical Catalyst Grant by UK’s leading public funding body, Innovate UK.

Next
Next

ImmTune Therapies is one of the top 3 finalists for Merck’s emerging biotechs grant programme, aimed at supporting young biotechs with Merck’s expertise.